Understanding thrombocytopenia in patients with portal hypertension and chronic liver disease
Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal hypertension…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…
Lab-grown organoid offers a platform to study how liver scarring develops
As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates…
Groundbreaking 3D dynamic cell co-culture models simulate MASLD progression
In a recent work published in BME Frontiers, a collaborative study by researchers from Griffith University, Queensland University…
Scientists question the safety and efficacy of the diet for metabolic health
A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects…
Nanoparticles offer new hope for treating alcohol-related liver disease
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Coffee protects the liver by blocking inflammation and scarring, review finds
Scientists reveal how your daily cup of coffee may guard against liver disease, connecting population trends with the…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Genetic mutation in some East Asians linked to aldehyde storm and increased liver disease risk
Researchers have identified the mechanism by which a common genetic mutation increases liver disease risk. Their findings suggest…